Prediction of Treatment Efficacy and Telaprevir-Resistant Variants after Triple Therapy in Patients Infected with Hepatitis C Virus Genotype 1

It is often difficult to predict the response to telaprevir-pegylated interferon (PEG-IFN)-ribavirin triple therapy and the appearance of telaprevir-resistant variants. The present study determined the predictive factors of a sustained virological response (SVR) to 12- or 24-week triple therapy (T12...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Akuta, Norio, Suzuki, Fumitaka, Fukushima, Taito, Kawamura, Yusuke, Sezaki, Hitomi, Suzuki, Yoshiyuki, Hosaka, Tetsuya, Kobayashi, Masahiro, Hara, Tasuku, Kobayashi, Mariko, Saitoh, Satoshi, Arase, Yasuji, Ikeda, Kenji, Kumada, Hiromitsu
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2013
Materias:
Virology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3754631/
https://ncbi.nlm.nih.gov/pubmed/23784126
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.01129-13
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares